Plastic and Reconstructive Surgery, Global Open (Aug 2023)

A Retrospective Study Analyzing Opioid Prescription Practices in Hand Surgery from 2013 to 2019

  • India Rangel, BS,
  • Maya T. Harrington, MBA,
  • Nellie V. Movtchan, MD,
  • Lyndsay A. Kandi, BS,
  • Javier Janbieh, BS,
  • Jordan R. Pollock, MBA,
  • Erwin Kruger, MD,
  • Jason H. Ko, MD, MBA,
  • Chad M. Teven, MD

DOI
https://doi.org/10.1097/GOX.0000000000005218
Journal volume & issue
Vol. 11, no. 8
p. e5218

Abstract

Read online

Background:. The potential for opioid prescription medication addiction and abuse has been a growing concern in healthcare. It is not uncommon for hand surgery patients to be overprescribed opioid medication for postoperative pain management. The objective of this study was to characterize changes in opioid prescription practices of hand surgeons treating Medicare Part D patients from 2013 to 2019. Methods:. A retrospective analysis of Medicare Part D prescriber data from 2013 to 2019 was conducted. This database provides information on drugs paid for under the Medicare Part D Prescription Drug Program. For each prescriber and medication, the dataset includes the total number of prescriptions dispensed (original prescriptions and number of refills), and total medication cost. Results:. In 2013, the 10 most common medications prescribed totaled 114,409 prescriptions, with 89,701 (78.4%) opioid prescriptions. In 2019, the 10 most common medications prescribed totaled 164,955 prescriptions, with 109,665 (66.5%) opioid prescriptions. Although total opioid prescriptions dropped, there was a 22% increase in the total number of prescriptions written. The two most common medications prescribed, hydrocodone-acetaminophen and oxycodone-acetaminophen, totaled 75,796 in 2013, compared with 76,518 in 2019. The overall number of prescriptions for nonsteroidal anti-inflammatory drugs increased by 157%, and the percentage of total opioids prescribed declined by 7.9%. Conclusions:. The increase in total opioid prescriptions from 2013 to 2019 by hand surgeons in the Medicare Part D Prescription Drug Program lags behind the recommended shift to nonopioid pain management. The reasons for the overall rise in prescriptions deserve further exploration.